Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intraportal vs kidney subcapsular site for human pancreatic islet transplantation.

Literature DB >> 9532100

Intraportal vs kidney subcapsular site for human pancreatic islet transplantation.

R M Jindal¹, R A Sidner, H B McDaniel, M S Johnson, S E Fineberg.

Abstract

Entities: Disease Species

Mesh：

Year: 1998 PMID： 9532100 DOI： 10.1016/s0041-1345(97)01327-4

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

Review 1. Islet transplantation: alternative sites.

Authors: Amer Rajab
Journal: Curr Diab Rep Date: 2010-10 Impact factor: 4.810

2. An engineered cell sheet composed of human islets and human fibroblast, bone marrow-derived mesenchymal stem cells, or adipose-derived mesenchymal stem cells: An in vitro comparison study.

Authors: Hajime Imamura; Tomohiko Adachi; Tatsuya Kin; Shinichiro Ono; Yusuke Sakai; Toshiyuki Adachi; Akihiko Soyama; Masaaki Hidaka; Mitsuhisa Takatsuki; A M James Shapiro; Susumu Eguchi
Journal: Islets Date: 2018-04-02 Impact factor: 2.694

Review 3. Considerations for an Alternative Site of Islet Cell Transplantation.

Authors: Poppy Addison; Karina Fatakhova; Horacio L Rodriguez Rilo
Journal: J Diabetes Sci Technol Date: 2019-08-09

4. Comparison of four pancreatic islet implantation sites.

Authors: Hyoung-Il Kim; Jae Eun Yu; Chung-Gyu Park; Sang-Joon Kim
Journal: J Korean Med Sci Date: 2009-01-19 Impact factor: 2.153

5. Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone.

Authors: Undine Schubert; Janine Schmid; Susann Lehmann; Xian Y Zhang; Henning Morawietz; Norman L Block; Waldemar Kanczkowski; Andrew V Schally; Stefan R Bornstein; Barbara Ludwig
Journal: Proc Natl Acad Sci U S A Date: 2013-01-23 Impact factor: 11.205

10. Local, Controlled Release In Vivo of Vascular Endothelial Growth Factor Within a Subcutaneous Scaffolded Islet Implant Reduces Early Islet Necrosis and Improves Performance of the Graft.

Authors: John A Gebe; Anton Preisinger; Michel D Gooden; Leonard A D'Amico; Robert B Vernon
Journal: Cell Transplant Date: 2018-05-14 Impact factor: 4.064

Intraportal vs kidney subcapsular site for human pancreatic islet transplantation.

Review 1. Islet transplantation: alternative sites.

2. An engineered cell sheet composed of human islets and human fibroblast, bone marrow-derived mesenchymal stem cells, or adipose-derived mesenchymal stem cells: An in vitro comparison study.

Review 3. Considerations for an Alternative Site of Islet Cell Transplantation.

4. Comparison of four pancreatic islet implantation sites.

5. Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone.

Review 6. Islet cell transplant and the incorporation of Tregs.

Review 7. The Spleen as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem Cells.

Review 8. Revascularization of transplanted pancreatic islets and role of the transplantation site.

Review 9. Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges.

10. Local, Controlled Release In Vivo of Vascular Endothelial Growth Factor Within a Subcutaneous Scaffolded Islet Implant Reduces Early Islet Necrosis and Improves Performance of the Graft.